Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for AGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -14.71M
March 31, 2026 -7.447M
December 31, 2025 -8.571M
September 30, 2025 -9.13M
June 30, 2025 -12.15M
March 31, 2025 -6.365M
December 31, 2024 -7.085M
September 30, 2024 -13.02M
June 30, 2024 -2.024M
March 31, 2024 -17.34M
December 31, 2023 -10.54M
September 30, 2023 -20.43M
June 30, 2023 -40.29M
March 31, 2023 -58.14M
December 31, 2022 -24.02M
September 30, 2022 -28.29M
June 30, 2022 -27.84M
March 31, 2022 -16.17M
December 31, 2021 -71.86M
September 30, 2021 -80.66M
June 30, 2021 -12.22M
March 31, 2021 -63.38M
December 31, 2020 -25.05M
September 30, 2020 -67.68M
June 30, 2020 -20.83M
Date Value
March 31, 2020 -67.33M
December 31, 2019 -1.356M
September 30, 2019 -0.115M
June 30, 2019 0.00
March 31, 2019 -30.17M
December 31, 2018 -43.52M
September 30, 2018 -13.56M
June 30, 2018 -22.64M
March 31, 2018 -6.318M
December 31, 2017 -2.035M
September 30, 2017 -0.4915M
June 30, 2017 -1.352M
March 31, 2017 -62.14M
December 31, 2016 -2.258M
September 30, 2016 0.0457M
June 30, 2016 -0.0343M
March 31, 2016 -0.4371M
December 31, 2015 -0.0114M
September 30, 2015 -0.2682M
June 30, 2015 -75.26M
March 31, 2015 -36.11M
December 31, 2014 -0.1018M
September 30, 2014 56.73M
June 30, 2014 -0.125M
March 31, 2014 -56.75M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Novavax, Inc. -1.727M
Amgen, Inc. 0.00
Anika Therapeutics, Inc. 0.643M
BioCryst Pharmaceuticals, Inc. -6.247M
Imunon, Inc. -3.131M